Acacia Pharma is a hospital pharmaceutical company devoted to the development and commercialization of novel nausea and vomiting treatments for surgical and cancer patients. Founded in 2007, we are based in Cambridge, UK, with US operations in Indianapolis, IN. Our management team has extensive experience in the discovery, development, and commercialization of supportive care pharmaceutical products, along with the identification of drugs marketed for other uses that may have biological properties appropriate for development as supportive care therapies.